Synchron Inc.

05/26/2026

Caregivers play an essential role in clinical trials. If your loved one is living with , encourage them to speak with their doctor about the . Together, we’re building new possibilities for care and independence. ��

🔗 Learn more and register your loved one here: https://synchronbci.com/?utm_source=patient_advocacy_group&utm_medium=Market_Development_General&utm_campaign=patient_recruitment&r=37

05/20/2026

🚨 Enrollment NOW OPEN at select U.S. sites! INTENT trial: evaluating BCI safety + independence in .

📌 Register ➡️ https://synchronbci.com/?utm_source=patient_advocacy_group&utm_medium=Market_Development_General&utm_campaign=patient_recruitment&r=37

05/18/2026

What is the INTENT trial?

✅ INTENT stands for INdependence Through Endovascular Neuroprosthetic Technology
✅ FDA-approved clinical trial
✅ Evaluating safety of Synchron’s brain-computer interface (BCI)
✅ Exploring how BCI may improve communication and independence

🔗 Learn more and register: https://synchronbci.com/?utm_source=patient_advocacy_group&utm_medium=Market_Development_General&utm_campaign=patient_recruitment&r=37

05/18/2026

Don't miss our upcoming webinar with MND Australia! We'll share insights on what a BCI is, how it works, and how it's being developed for people living with motor neurone disease.

Join MND Australia and Synchron for a webinar exploring Synchron’s Brain-Computer Interface (BCI) technology – what it is, how it works, and how it's being developed for people living with motor neurone disease.

Date: Wednesday, 3 June 2026
Time: 12pm AEST
Register: https://bci-webinar.researchstudytrialau.com/

Brain-Computer Interface (BCI) is a small, implanted medical device designed to help people control digital devices using only their thoughts, without the need for eye tracking, voice commands, or hand movements.

In April 2026, Synchron launched the next phase of their FOCUS-AUS Study in Australia, designed to continue to evaluate safety while also exploring how Synchron’s BCI may improve quality of life for people with motor impairments.

The webinar will include insights from past research participants and outcomes from Synchron’s prior clinical trials.

Registrants will have the opportunity to join the Synchron BCI Community, and stay up-to-date on current happenings and clinical trial opportunities.

Register for the webinar: https://bci-webinar.researchstudytrialau.com/

05/06/2026

We’ve opened enrollment for our Australian clinical trial evaluating Synchron’s minimally invasive brain-computer interface.

The study will take place across sites in Melbourne and Sydney, supporting people living with motor neuron disease (MND). The goal of this study is to assess whether participants can control digital devices with their thoughts—enabling everyday actions like sending messages, browsing the internet, and operating smart home technologies.

This marks an important step forward in the broader clinical evaluation of brain-computer interface technology.

Our goal is to restore independence and communication for patients living with severe paralysis, without the need for open brain surgery.

Australia is a key part of our global clinical strategy, and we’re proud to advance this work in the country where Synchron was founded.

The FOCUS-AUS patient registry is now live: https://synchronbci.com/

Watch this video interview between Nine and Rodney, an individual living with the Stentrode™ BCI implant:

The Synchron BCI is for clinical investigation use only.

04/28/2026

Incredible to see Synchron recognized by TIME on its inaugural Companies Industry Leaders list.

At Synchron, we’re advancing brain-computer interface technology to restore independence for people with paralysis, enabling connection and control through thought.

Congrats to the team, our partners, users and their families on this well-deserved recognition!

Read the article: https://time.com/article/2026/04/27/time100-companies-new-frontiers/

Learn more about our studies: https://synchronbci.com/

04/27/2026

Missed our live webinar with the The ALS Association? You can watch the full recording on YouTube.

Watch here: https://www.youtube.com/watch?v=HvJzywuQcJQ

We’re incredibly grateful for the opportunity to connect with this community and share more about brain-computer interfaces ( )—what they are, how they work, and where they’re headed.

We’re building this future with the community, and moments like these are an essential part of that journey.

Brain-Computer Interfaces (BCIs) are an emerging technology that may restore connection and independence for people living with ALS. In this webinar, Synchro...

04/22/2026

Honored to be a sponor for the inaugural ALS Advance: National Meetings hosted by ALS Canada!

This week, April 24-26, ALS Canada is proud to host the inaugural ALS Advance: National Meetings. This coordinated series of meetings focuses on the exchange of information to accelerate progress toward , and brings together researchers, clinicians, early‑career talent, health care professionals, and community members.

We would like to thank the sponsors of ALS Advance, ALS Disrupt, and ALS Exchange for their support and generosity – fostering knowledge sharing and collaborative discussion.

Thank you to Shionogi Canada Inc., Biogen Canada, Prilenia Therapeutics, Stiris Research Inc, Synchron Inc., and Trace Neuroscience for helping us make this happen!

04/16/2026

In case you missed it: Last year Synchron was honored to be the BCI company invited to speak at The The ALS Association .

👀 Check out our session on YouTube: https://www.youtube.com/watch?v=8WtZdVrhUeI

We shared the latest on our BCI research and, more importantly, how your lived experience is shaping what’s next. Through our partnership we’ve gotten to know the needs of pALS on a deeper level through sponsored market research and BCI education.

Want to help shape the future of BCI? Hit the follow button and join our community!

Recorded at the Hope and Help Symposium held on Saturday, September 20, 2025

04/15/2026

What does 10 years of innovation look like?

From our founding in Australia to our latest breakthroughs in the U.S., we’ve been on a mission to build the future of connection alongside our community.

Check out this recap of our journey and meet some of the incredible people shaping Synchron.

Want to stay informed? Hit that follow button and join our 3,000+ member community today at www.synchronbci.com! ❤️

04/14/2026

📣 Big news: FDA approval granted for Synchron’s INTENT trial.

The INTENT trial will evaluate safety and explore how brain-computer interface ( ) technology may support communication, independence, and improved quality of life for people living with ALS.

Learn more: https://synchronbci.com/?utm_source=patient_advocacy_group&utm_medium=PR_Newsrelease&utm_campaign=patient_recruitment&r=33